Risk Factors Update Summary
- Introduction of new high-cost specialty drugs and sudden cost spikes could jeopardize actuarial soundness.
- Established a premium deficiency reserve for 2024 Medicare Advantage business as of December 31, 2023.
- The Inflation Reduction Act (IRA) may substantially increase PDP's risk exposure in 2025.
- Medicare Advantage 2024 rate decrease combined with quality scores led to premium deficiency reserve.
- Failure to accurately predict demand for products could negatively impact staffing and service levels.
- Suspended Medicare Part D bids sequestration until March 31, 2025, creating additional uncertainty.
- Changes in the competitive market may adversely affect pricing flexibility and control over medical cost trends.
- Failure to adapt to industry shifts could negatively impact competitiveness and client retention.
- Data security risks have significantly increased, requiring substantial resources for system modifications.
- Inability to attract and retain qualified personnel may impact operational expansion and growth.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1071739&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.